Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Inventory (2025)

Abeona Therapeutics (ABEO) has 4 years of Inventory data on record, last reported at $4.8 million in Q3 2025.

  • For Q3 2025, Inventory changed N/A year-over-year to $4.8 million; the TTM value through Sep 2025 reached $4.8 million, changed N/A, while the annual FY2012 figure was $194000.0, 28.48% up from the prior year.
  • Inventory reached $4.8 million in Q3 2025 per ABEO's latest filing, up from $2.7 million in the prior quarter.
  • Across five years, Inventory topped out at $4.8 million in Q3 2025 and bottomed at $2.7 million in Q2 2025.